Cardiac Rhythm Disorder clinical trials at University of California Health
2 research studies open to eligible people
open to eligible people ages 18 years and up
Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
open to all eligible people
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Our lead scientists for Cardiac Rhythm Disorder research studies include Ulrika Birgersdotter-Green.